Drug Chatter -- Tracking biopharma stock chatter

Profile for VBI Vaccines Inc. (VBIV)

« Back to company index

VBIV Chatter Timeline

Stock Ticker for VBIV

Most Active Tweeters for VBIV

UserTweets
@biotech_sector 4
@SPNewsAnalysis 4
@chaffeybreeze 3
@TheMarketsDaily 3
@IRAMarketReport 3

Recent Tweets for VBIV

LifeSci_PR @LifeSci_PR
RT @LifeSciAdvisors: VBI Vaccines $VBIV: Announces Positive Data from Ph1 Study of Preventative CMV Vaccine https://t.co/NtwGcY60WW
July 27th 2017, 1:07pm
StockNewsNow @StockNewsNow
$VBIV VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine https://t.co/8R6f0tBk80
July 27th 2017, 12:07pm
biotech_sector @biotech_sector
#VBIVaccines BRIEF-#accines announces interim data from Phase 1 study of preventative CMV v... Read more: https://t.co/dkX0zoel5c $VBIV
July 27th 2017, 11:07am
LifeSciAdvisors @LifeSciAdvisors
VBI Vaccines $VBIV: Announces Positive Data from Ph1 Study of Preventative CMV Vaccine https://t.co/NtwGcY60WW
July 27th 2017, 10:07am
iTwitsTrade @iTwitsTrade
$VBIV (Positive results from a planned, interim data read-out from a Phase 1 study of its preventative cytomegalovi… https://t.co/tT7wJD6wss
July 27th 2017, 10:07am
tickerws @tickerws
$VBIV CMV vaccine candidate shows positive effect in early-stage study; shares ahead 3% https://t.co/9G2kfPAigv
July 27th 2017, 10:07am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
VBI's CMV vaccine candidate shows positive effect in early-stage study; shares ahead 3% https://t.co/AbTPMJ9NX2 $VBIV
July 27th 2017, 10:07am
MarketCurrents @MarketCurrents
VBI's CMV vaccine candidate shows positive effect in early-stage study; shares ahead 3% https://t.co/Dzw6FBXzfz $VBIV
July 27th 2017, 10:07am
Briefingcom @Briefingcom
$VBIV: VBI Vaccines announced positive results from a planned, interim data read-out from a Phase 1 study of its... https://t.co/UFIfjNc0ix
July 27th 2017, 9:07am
stockboardinc @stockboardinc
$VBIV VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine... - https://t.co/RaURxqGqZT
July 27th 2017, 7:07am
EEthougths @EEthougths
VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine $VBIV
July 27th 2017, 7:07am
jrodcna @jrodcna
RT @CNAFinance: $VBIV here's what you need to know! https://t.co/R087DGhVs3 https://t.co/vgoodhELsz
July 24th 2017, 12:07pm
CNAFinance @CNAFinance
$VBIV here's what you need to know! https://t.co/R087DGhVs3 https://t.co/vgoodhELsz
July 24th 2017, 12:07pm
itsmepanda1 @itsmepanda1
RT @biotech_sector: #VBIVaccines #accines Meets With FDA for Upcoming Trial of Hepatitis B Vaccine. Read more: https://t.co/CjVmzAMxcv $VBIV
July 24th 2017, 12:07am
biotech_sector @biotech_sector
#VBIVaccines #accines, Inc. Short Interest Up 163.4% in June. Read more: https://t.co/ct1wIsalBx $VBIV
July 22nd 2017, 3:07pm
biotech_sector @biotech_sector
#VBIVaccines #accines Reports Phase 3 Clinical Program for Sci-B-Vac(TM) Hepatitis B Vaccine. Read more: https://t.co/YYc3KdgqDz $VBIV
July 22nd 2017, 3:07pm
SleekMoneycom @SleekMoneycom
VBI Vaccines, Inc. $VBIV Short Interest Update https://t.co/dLYl8ub1CC
July 21st 2017, 8:07am
SPNewsAnalysis @SPNewsAnalysis
VBI Vaccines $VBIV Getting Somewhat Positive Press Coverage, Report Finds https://t.co/LyTVLMd9t1
July 20th 2017, 12:07pm
storminvestor @storminvestor
VBI Vaccines $VBIV Getting Somewhat Positive Press Coverage, Report Finds https://t.co/ZjUHHyskVj
July 20th 2017, 12:07pm
LifeSciAdvisors @LifeSciAdvisors
With eyes on Glaxo's Engerix-B vaccine, $VBIV takes hep B candidate into phase 3 https://t.co/jiFv1iHMIr
July 19th 2017, 4:07pm
TheMarketsDaily @TheMarketsDaily
VBI Vaccines, Inc. $VBIV Short Interest Up 163.4% in June https://t.co/NAp0lUUOwX
July 19th 2017, 8:07am
biotech_sector @biotech_sector
#VBIVaccines #accines, Inc. Short Interest Up 163.4% in June. Read more: https://t.co/XynBExQhIK $VBIV
July 19th 2017, 5:07am
ZolmaxNews @ZolmaxNews
VBI Vaccines, Inc. $VBIV Short Interest Up 163.4% in June https://t.co/30Ec3rYTJW
July 19th 2017, 3:07am
chaffeybreeze @chaffeybreeze
VBI Vaccines $VBIV Earns Daily News Sentiment Rating of 0.29 https://t.co/GSOTzRAMH7
July 16th 2017, 12:07pm
IRAMarketReport @IRAMarketReport
VBI Vaccines $VBIV Earns Daily News Sentiment Rating of 0.29 https://t.co/QFiWYmLx6i
July 16th 2017, 12:07pm
WatchlistN @WatchlistN
VBI Vaccines $VBIV Earns Daily News Sentiment Rating of 0.29 https://t.co/GVDYKkpwpW
July 16th 2017, 12:07pm
chaffeybreeze @chaffeybreeze
VBI Vaccines, Inc. $VBIV Short Interest Up 163.4% in June https://t.co/dUhyENisY5
July 16th 2017, 7:07am
IRAMarketReport @IRAMarketReport
VBI Vaccines, Inc. $VBIV Short Interest Up 163.4% in June https://t.co/YPuzeHQDgk
July 16th 2017, 7:07am
intercooleronli @intercooleronli
VBI Vaccines, Inc. $VBIV Short Interest Up 163.4% in June https://t.co/UsB1Z7fqmX
July 16th 2017, 7:07am
SPNewsAnalysis @SPNewsAnalysis
VBI Vaccines, Inc. $VBIV Receives $5.38 Average Target Price from Analysts https://t.co/JhmFk3zIgl
July 15th 2017, 1:07pm
WatchlistN @WatchlistN
VBI Vaccines, Inc. $VBIV Receives $5.38 Average Target Price from Analysts https://t.co/seZH1TRwlR
July 15th 2017, 1:07pm
intercooleronli @intercooleronli
Zacks Investment Research Lowers VBI Vaccines, Inc. $VBIV to Hold https://t.co/9tPt3UqjbA
July 15th 2017, 10:07am
dakotafinancial @dakotafinancial
VBI Vaccines, Inc. $VBIV Rating Lowered to Hold at Zacks Investment Research https://t.co/v8flov2fz6
July 15th 2017, 8:07am
IRAMarketReport @IRAMarketReport
VBI Vaccines, Inc. $VBIV Downgraded to “Hold” at Zacks Investment Research https://t.co/G9RWsiPnUw
July 15th 2017, 8:07am
SPNewsAnalysis @SPNewsAnalysis
Zacks Investment Research Lowers VBI Vaccines, Inc. $VBIV to Hold https://t.co/Hp5jFnOobV
July 15th 2017, 8:07am
chaffeybreeze @chaffeybreeze
VBI Vaccines, Inc. $VBIV Downgraded to “Hold” at Zacks Investment Research https://t.co/BSqGvYHtqW
July 15th 2017, 8:07am
dailypoliticaln @dailypoliticaln
VBI Vaccines, Inc. $VBIV Lowered to “Hold” at Zacks Investment Research https://t.co/vPlC1LaX0G
July 15th 2017, 8:07am
emq_news @emq_news
VBI Vaccines, Inc. $VBIV Rating Lowered to Hold at Zacks Investment Research https://t.co/g33c1H4mqz
July 15th 2017, 7:07am
TickerReport @TickerReport
VBI Vaccines, Inc. $VBIV Rating Lowered to Hold at Zacks Investment Research https://t.co/UiXwgJd8C3
July 15th 2017, 7:07am
TickerReport @TickerReport
VBI Vaccines, Inc. $VBIV Rating Lowered to Hold at Zacks Investment Research https://t.co/C5l3QmVpdi
July 15th 2017, 7:07am
TheMarketsDaily @TheMarketsDaily
VBI Vaccines, Inc. $VBIV Lowered to “Hold” at Zacks Investment Research https://t.co/L1epeOnZ5c
July 15th 2017, 7:07am
midetimes @midetimes
VBI Vaccines, Inc. $VBIV Lowered to “Hold” at Zacks Investment Research https://t.co/kEkfFGjU8d
July 15th 2017, 7:07am
RatingsNetwork @RatingsNetwork
VBI Vaccines downgraded by Zacks Investment Research to hold. https://t.co/P7gGa3Ly0n $VBIV #VBIV
July 15th 2017, 7:07am
SPNewsAnalysis @SPNewsAnalysis
VBI Vaccines $VBIV Earning Somewhat Negative News Coverage, Report Shows https://t.co/idwIXnhHNc
July 14th 2017, 8:07pm
dailypoliticaln @dailypoliticaln
VBI Vaccines, Inc. $VBIV Stock Rating Upgraded by ValuEngine https://t.co/RsJ5OkdPAi
July 14th 2017, 10:07am
TheMarketsDaily @TheMarketsDaily
VBI Vaccines, Inc. $VBIV Lowered to Hold at Zacks Investment Research https://t.co/tScgJllp6e
July 14th 2017, 12:07am
biotech_sector @biotech_sector
#VBIVaccines #accines to study Sci-B-Vac in Phase III programme for hepatitis B ... Read more: https://t.co/HakJl3JGXX $VBIV
July 13th 2017, 2:07pm
pharma_sector @pharma_sector
#VBIVaccines #accines to study Sci-B-Vac in Phase III programme for hepatitis B ... Read more: https://t.co/mIkjYqny5m $VBIV
July 13th 2017, 2:07pm
mariempowers @mariempowers
RT @BioWorld: $VBIV mounts ambitious ph 3 program for Sci-B-Vac in HBV, targeting filings in US, EU, Canada
July 12th 2017, 12:07pm
BioWorld @BioWorld
$VBIV mounts ambitious ph 3 program for Sci-B-Vac in HBV, targeting filings in US, EU, Canada
July 12th 2017, 12:07pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.